The use of ‘decision support’ computer software can significantly improve the management of patients concerned about their family history of breast and bowel cancer, according to a study published in the British Journal of Cancer* today (Tuesday).
As of 10_August 2007, the Therapeutic Goods Administration, Australia, TGA had received eight reports of serious liver adverse reactions associated with use of lumiracoxib, including two deaths and two patients requiring liver transplants.
Mayo Clinic researchers have identified the first immune molecule that appears to play a role in prostate cancer development and in predicting cancer recurrence and progression after surgery. The report on the B7-H3 molecule by Mayo Clinic Cancer Center appears today in Cancer Research.
The lipid measure apolipoprotein (apo) B: apo A-I ratio is not a better predictor of coronary heart disease risk than traditional lipid ratios that include total cholesterol and HDL-C, according to a study in the August 15 issue of JAMA.
More than 4,000 children in China who have received cochlear implants and other devices will soon benefit from a speech perception test offered in Mandarin. The Mandarin Early Speech Perception (MESP) test was developed in collaboration between Sigfrid D. Soli, Ph.D., of the House Ear Institute in Los Angeles and Yun Zheng, MD, of the West China Hospital of Sichuan University in Chengdu, and exclusively licensed to Cochlear Limited for use in evaluation of pediatric cochlear implant recipients in China.
Is there a definitive test for mental illness? Not yet, but using advanced neuropsychiatric diagnostic tools including magnetic resonance imaging (MRI) and positron emission tomography (PET), mental health professionals at The Menninger Clinic in Houston are pinpointing the causes of behavioral and psychiatric problems in patients.
In accordance with contingency planning arrangements vaccination is at the forefront of disease control policy in Foot and Mouth Disease outbreaks. Arrangements for possible vaccination were triggered immediately disease was confirmed on Friday 3rd_August.
Many common diseases exhibit gender bias and gender differences have been observed in the development of high blood pressure (hypertension) and heart (cardiovascular) disease.
In a new study, researchers examined the differential contribution of genetic factors involved in regulating blood pressure based on samples drawn from a large community. They found significant differences in genetic contributors to blood pressure in males vs. females.
The UK Health and Safety Executive HSE publishes initial report on potential breaches of biosecurity at the Pirbright site. The Chief Executive of the Health and Safety Executive (HSE) Geoffrey Podger said: